Yonatan Edel
Impact in
-
- MicroRNA in disease regulation
Papers in
-
- Porphyrin Metabolism and Disorders 9
- Heme Oxygenase-1 and Carbon Monoxide 8
-
- Methemoglobinemia and Tumor Lysis Syndrome 5
- Co-authors
- Rivka Mamet (6 shared papers)Meir Lahav (4 shared papers)Einat Beery (2 shared papers)Orit Uziel (2 shared papers)Hadar Goldvaser (4 shared papers)Ofir Wolach (3 shared papers)Jardena Nordenberg (1 shared paper)Anna Gutkin (1 shared paper)
In The Last Decade
Yonatan Edel
25 papers receiving 233 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 36
- Aging 4
- Rheumatology 30
- Molecular Biology 116
- Pediatrics, Perinatology and Child Health 33
Countries citing papers authored by Yonatan Edel
This map shows the geographic impact of Yonatan Edel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonatan Edel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonatan Edel more than expected).
Fields of papers citing papers by Yonatan Edel
This network shows the impact of papers produced by Yonatan Edel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonatan Edel. The network helps show where Yonatan Edel may publish in the future.
Co-authors
The 25 scholars most cited alongside Yonatan Edel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 48 | |
| 2 | 2018 | 23 | |
| 3 | 2023 | 21 | |
| 4 | 2018 | 20 | |
| 5 | 2019 | 14 | |
| 6 | A Cross-sectional Survey on the Preference of Patients with Rheumatoid Arthritis for Route of Administration of Disease-Modifying Anti-Rheumatic Drugs: Oral Target-Specific Versus Parenteral Biologic. | 2020 | 14 |
| 7 | 2023 | 12 | |
| 8 | 2024 | 11 | |
| 9 | 2019 | 11 | |
| 10 | 2011 | 10 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2019 | 7 | |
| 14 | 2014 | 6 | |
| 15 | 2015 | 5 | |
| 16 | 2019 | 4 | |
| 17 | 2013 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 2020 | 1 |
About Yonatan Edel
Yonatan Edel is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Rheumatology, Pediatrics, Perinatology and Child Health and Oncology, having authored 27 papers that have together received 237 indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (9 papers), Heme Oxygenase-1 and Carbon Monoxide (8 papers), Methemoglobinemia and Tumor Lysis Syndrome (5 papers), Inflammation biomarkers and pathways (2 papers), Apelin-related biomedical research (2 papers), Telomeres, Telomerase, and Senescence (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Neonatal Health and Biochemistry (2 papers). The work is most often cited by research in Cancer Research (36 citations), Aging (4 citations), Rheumatology (30 citations), Molecular Biology (116 citations) and Pediatrics, Perinatology and Child Health (33 citations). Yonatan Edel has collaborated with scholars based in Israel, Norway and Canada. Frequent co-authors include Rivka Mamet, Meir Lahav, Einat Beery, Orit Uziel, Hadar Goldvaser, Ofir Wolach, Jardena Nordenberg, Anna Gutkin, Daniel Shepshelovich and Razan Mansour. Their work appears in journals such as Photodermatology Photoimmunology & Photomedicine, Clinical and Experimental Rheumatology, Scientific Reports, British Journal of Cancer and Journal of Inherited Metabolic Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.